Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Heart Failure | Case report

Malignant mesothelioma associated with localized myocardial fibrosis: a case report

Authors: Kristyna Vymetalova, Pavol Tomasov, Rostislav Polasek

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Left ventricular dysfunction is a common reason for patients’ referral to cardiology departments for examination. Cardiac involvement is one of the possible yet rare presentations of malignant mesothelioma. We present a case of a patient in whom a routine cardiac examination and imaging revealed malignant mesothelioma. We discuss a possible association between a malignant tumor and myocardial scarring and how the oncologic treatment is influenced by concomitant heart failure. This article aims to raise awareness of the importance of multidisciplinary cooperation and thinking beyond the daily routine of our specialty to ensure the quality care of our patients. It also forced us to think about the possible causes of the association between malignant mesothelioma and myocardial fibrosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fernandes R, Nosib S, Thomson D, Baniak N. A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction. BMJ Case Rep. 2014;2014:bcr2013203194.CrossRef Fernandes R, Nosib S, Thomson D, Baniak N. A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction. BMJ Case Rep. 2014;2014:bcr2013203194.CrossRef
2.
go back to reference Wadler S, Chahinian P, Slater W, Goldman M, Mendelson D, Holland JF. Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma. Cancer. 1986;58:2744–50.CrossRef Wadler S, Chahinian P, Slater W, Goldman M, Mendelson D, Holland JF. Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma. Cancer. 1986;58:2744–50.CrossRef
3.
go back to reference Barroso AS, Leite S, Friões F, et al. Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction. Rev Port Cardiol. 2017;36:307.e1-307.e5.CrossRef Barroso AS, Leite S, Friões F, et al. Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction. Rev Port Cardiol. 2017;36:307.e1-307.e5.CrossRef
4.
go back to reference Demerouti E, Petrou E, Karatasakis G, Mastorakou I, Athanassopoulos G. First application of coronary flow reserve measurement for the assessment of left main compression syndrome in pulmonary hypertension. Can J Cardiol. 2015;31(4):548.CrossRef Demerouti E, Petrou E, Karatasakis G, Mastorakou I, Athanassopoulos G. First application of coronary flow reserve measurement for the assessment of left main compression syndrome in pulmonary hypertension. Can J Cardiol. 2015;31(4):548.CrossRef
5.
go back to reference Yassin NY, Tomasov P, Horak J, Polasek R. Occlusion of epicardial coronary arteries by localized pericardial calcification. J Am Coll Cardiol Case Rep. 2019;1(4):671–2. Yassin NY, Tomasov P, Horak J, Polasek R. Occlusion of epicardial coronary arteries by localized pericardial calcification. J Am Coll Cardiol Case Rep. 2019;1(4):671–2.
6.
go back to reference Lollert A, Emrich T, Eichstädt J, Kampmann C, Abu-Tair T, Turial S, et al. Differences in myocardial strain between pectus excavatum patients and healthy subjects assessed by cardiac MRI: a pilot study. Eur Radiol. 2017;28(3):1276–84.CrossRef Lollert A, Emrich T, Eichstädt J, Kampmann C, Abu-Tair T, Turial S, et al. Differences in myocardial strain between pectus excavatum patients and healthy subjects assessed by cardiac MRI: a pilot study. Eur Radiol. 2017;28(3):1276–84.CrossRef
7.
go back to reference Lisowska A, Knapp M, Sobkowicz B, Musiał WJ. Severe right-ventricular heart failure due to malignant pericardial mesothelioma. Kardiol Pol. 2005;63(5):569–70.PubMed Lisowska A, Knapp M, Sobkowicz B, Musiał WJ. Severe right-ventricular heart failure due to malignant pericardial mesothelioma. Kardiol Pol. 2005;63(5):569–70.PubMed
8.
go back to reference Chu GJ, van Zandwijk N, Rasko JEJ. The immune microenvironment in mesothelioma: mechanisms of resistance to immunotherapy. Front Oncol. 2019;9:1366.CrossRef Chu GJ, van Zandwijk N, Rasko JEJ. The immune microenvironment in mesothelioma: mechanisms of resistance to immunotherapy. Front Oncol. 2019;9:1366.CrossRef
Metadata
Title
Malignant mesothelioma associated with localized myocardial fibrosis: a case report
Authors
Kristyna Vymetalova
Pavol Tomasov
Rostislav Polasek
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02079-2

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue